Characteristics of patients with hepatitis C virus with and without GB virus C/hepatitis G virus co-infection and efficacy of interferon alfa

Hepatology

Volumn 27, Issue 5, 1998, Pages 1388-1393

  Enomoto, Masaru ^a   Nisihiguchi, Shuhei ^a   Fukuda, Katsuhiko ^a   Kuroki, Tetsuo ^a   Tanaka, Motoharu ^a   Otani, Shuzo ^a   Ogami, Masayuki ^a   Monna, Takeyuki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; HEPATITIS C ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C VIRUS; HEPATITIS G VIRUS; HUMAN; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS HEPATITIS;

ADULT; FEMALE; FLAVIVIRIDAE; HEPATITIS ANTIBODIES; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; RNA, VIRAL; TIME FACTORS;

EID: 0031960449     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270528     Document Type: Article

References (8)

1. Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, Muerhoff AS, et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci U S A 1995;92:3401-3405.
2. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, Desai SM, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995;1:564-569.
3. Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, Schlauder GG, et al. Sequence and genomic organization of GBV-C: a novel member of the Flaviviridae associated with human non-A-E hepatitis. J Med Virol 1996;48:60-67.
4. Linnen J, WagesJ Jr, Zhang-Keck Z-Y, Fry KE, Krawczynski KZ, Alter H, Koonin E, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-508.
5. Tanaka E, Alter HJ, Nakatsuji Y, Shih W-K, Kim JP, Matsumoto A, Kobayashi M, et al. Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med 1996;125:740-743.
6. Berg T, Dirla U, Naumann U, Heuft H-G, Küther S, Lobeck H, Schreier E, et al. Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus. J Hepatol 1996;25:763-768.
7. Pilot-Matias TJ, Carrick RJ, Coleman PF, Leary TP, Surowy TK, Simons JN, Muerhoff AS, et al. Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serologic marker. Virology 1996;225:282-292.
8. Tacke M, Kiyosawa K, Stark K, Schlueter V, Ofenloch-Haehnle B, Hess G, Engel AM. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 1997;349:318-320.